HEALTH & LIFE SCIENCES NEWS
HEALTH & LIFE SCIENCES NEWS
Exploring critical business and legal issues across the healthcare and life sciences industries
HEALTH & LIFE SCIENCES NEWS
Exploring critical business and legal issues across the healthcare and life sciences industries

This Week in 340B: September 15 – 21, 2026

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: Contract Pharmacy; Other

  • In a case brought by a drug manufacturer challenging a Missouri state law governing contract pharmacy arrangements, the court denied the petitions for a panel rehearing and rehearing en banc.
  • In a qui tam action arguing that private parties can bring suits to enforce the 340B Statute, the defendants filed replies in support of their renewed motion to dismiss the first amended complaint and a reply in support of their renewed request for judicial notice.
  • In a case brought by a drug manufacturer challenging a Mississippi state law governing contract pharmacy arrangements, the manufacturer filed an appeal.
  • In a case brought by a trade association challenging a Mississippi state law governing contract pharmacy arrangements, the trade association filed a motion for abeyance and administrative closure.
  • In a case alleging that a health plan systematically underpaid hospitals by improperly discounting claims, the parties settled and dismissed the case.
  • In a case brought by a drug manufacturer challenging a Colorado state law [...]

    Continue Reading



This Week in 340B: September 8 – 14, 2026

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: Contract Pharmacy; Other

  • In a case brought by a drug manufacturer seeking judgment on its interpretation of the definition of “patient”, the intervenor-defendants filed a joint reply in support of motion to dismiss and the plaintiff filed a motion to strike or, in the alternative, for leave to file a surreply in opposition to Defendant’s motion to dismiss.
  • The parties involved in an action brought by the State of Arkansas against a group of drug manufacturers alleging that the manufacturers’ restrictive 340B policies violate state law filed a joint motion to remove the case to federal court.
  • In two cases brought by drug manufacturers challenging a Utah state law governing contract pharmacy arrangements, the plaintiffs filed responses to the defendant’s notice of supplemental authority.
  • In a combined case brought by drug manufacturers challenging a New Mexico state law governing contract pharmacy arrangements, the court granted American Hospital Association’s, 340B Health’s, and the American Society of Health-System Pharmacists’ motions for leave to file [...]

    Continue Reading



This Week in 340B: September 1 – 7, 2026

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: Contract Pharmacy; Other

  • In a case brought by a drug manufacturer challenging a Missouri state law governing contract pharmacy arrangements, defendants and intervenors filed reply suggestions in support of their respective motions for summary judgment.
  • In five cases brought by drug manufacturers and a trade association for drug manufacturers challenging an Illinois state law governing contract pharmacy arrangements, the defendant filed a combined response in opposition to the plaintiffs’ motions for preliminary injunction.
  • In a combined case brought by a drug manufacturer and a trade association for drug manufacturers challenging a Hawaii state law governing contract pharmacy arrangements, a nonparty filed a response to a status report, and the plaintiff filed a reply to the nonparty’s response.
  • A 340B covered entity filed a complaint against the government, arguing that the Government violated the Administrative Procedures Act when it denied the entity’s application for reinstatement as a DSH because it did not submit an attestation with documentation that had been uploaded to OPAIS within [...]

    Continue Reading



This Week in 340B: August 25 – 31, 2026

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: Contract Pharmacy; Other

  • In three separate cases brought by 340B covered entities against a group of pharmacy benefit managers and their vertically-integrated pharmacies alleging a breach of contract and violation of state laws, the covered entity plaintiffs filed an opposition to defendant’s motion to dismiss in each case.
  • In an appealed case brought by a drug manufacturer challenging a Missouri state law governing contract pharmacy arrangements, defendant-appellees and intervenors-appellees filed responses in opposition to en banc review.
  • In a case challenging defendants’ alleged diversion of 340B savings, plaintiffs filed a brief in opposition to defendants’ motion to dismiss.
  • In three cases brought by a drug manufacturer challenging an Illinois state law governing contract pharmacy arrangements, the court granted a motion to reassign cases as related for all further proceedings.
  • In a case brought by a trade association for drug manufacturers challenging an Illinois state law governing contract pharmacy arrangements, the court granted a motion to reassign cases as related for all further proceedings [...]

    Continue Reading



This Week in 340B: August 18 – 24, 2026

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: Contract Pharmacy; Other

  • In an appealed case brought by a drug manufacturer challenging a North Dakota state law governing contract pharmacy arrangements, the appellee filed its brief.
  • In a case brought by a drug manufacturer challenging a New Mexico state law governing contract pharmacy arrangements, the plaintiff filed a notice of supplemental authority.
  • In a case brought by a drug manufacturer challenging a Utah state law governing contract pharmacy arrangements, the plaintiff filed a notice of supplemental authority.
  • In a qui tam action arguing that private parties can bring suits to enforce the 340B Statute, the plaintiff-relators filed an opposition brief to defendants’ renewed motion to dismiss the first amended complaint.
  • In an appealed case brought by a drug manufacturer challenging a Missouri state law governing contract pharmacy arrangements, defendant-appellees and amici filed briefs in opposition to en banc review.
  • A 340B covered entity sued a group of pharmacy benefit managers and their vertically-integrated pharmacies, alleging a breach of contract and violation of [...]

    Continue Reading



STAY CONNECTED

TOPICS

ARCHIVES

Chambers 2021 Top Ranked
LEgal 500 EMEA top tier firm 2021
Legal 500 USA top tier firm
U.S. News Law Firm of the Year 2022 Health Care Law